|
King Pharmaceuticals, Inc - SWOT AnalysisPublished by: Datamonitor Published: Jun. 4, 2008 - 29 Pages Table of Contents
AbstractDatamonitor's King Pharmaceuticals, Inc - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.King Pharmaceuticals is a vertically integrated pharmaceutical company that develops, manufactures, markets and sells branded prescription pharmaceutical products. The company primarily operates in the US and Puerto Rico. The company is headquartered in Bristol, Tennessee and employs more than 2,000 people. The company recorded revenues of $2,136.9 million during the fiscal year ended December 2007, an increase of 7.5% over 2006. The increase was mainly due to the acquisition of Avinza in February 2007 and an increase in gross sales of the company’s Meridian Auto-Injector segment. The operating profit of the company was $227.5 million during fiscal year 2007, as compared to an operating profit of $402.5 million in 2006. The net profit was $182.9 million in fiscal year 2007, compared to a net profit of $288.9 million in 2006. Scope of the Report
Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||